Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis

Diabetes, Obesity & Metabolism
Yue MaJames Gardiner

Abstract

To investigate the role of arcuate glucokinase (GK) in the regulation of glucose homeostasis. A recombinant adeno-associated virus expressing either GK or an antisense GK construct was used to alter GK activity specifically in the hypothalamic arcuate nucleus (arc). GK activity in this nucleus was also increased by stereotactic injection of the GK activator, compound A. The effect of altered arc GK activity on glucose homeostasis was subsequently investigated using glucose and insulin tolerance tests. Increased GK activity specifically within the arc increased insulin secretion and improved glucose tolerance in rats during oral glucose tolerance tests. Decreased GK activity in this nucleus reduced insulin secretion and increased glucose levels during the same tests. Insulin sensitivity was not affected in either case. The effect of arc GK was maintained in a model of type 2 diabetes. These results demonstrate a role for arc GK in systemic glucose homeostasis.

References

Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P B IynedjianC B Newgard
Jul 1, 1973·Neuroscience and Behavioral Physiology·P TeichgraberZ D Pigareva
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jul 25, 2000·Diabetes·R M LynchB E Levin
May 22, 2002·Nature Neuroscience·Silvana ObiciLuciano Rossetti
Feb 18, 2003·The Journal of Clinical Investigation·Simon J Fisher, C Ronald Kahn
Apr 23, 2005·Nature·Alessandro PocaiLuciano Rossetti
Aug 2, 2005·Cell Metabolism·Alessandro PocaiLuciano Rossetti
Aug 6, 2005·Science·Tony K T LamLuciano Rossetti
Jan 10, 2006·Cell Metabolism·Richard W GellingMichael W Schwartz
Feb 8, 2006·Biological & Pharmaceutical Bulletin·Takashi NishioIchitomo Miwa
Jul 26, 2011·Diabetes & Metabolism Journal·Yeul Bum ParkYong Woon Kim
Dec 18, 2013·The Journal of Clinical Investigation·David TarussioBernard Thorens
Oct 1, 2014·Expert Opinion on Therapeutic Patents·Loranne Agius
Dec 9, 2014·The Journal of Clinical Investigation·Syed HussainJames Gardiner
Feb 24, 2015·The Biochemical Journal·Guy A RutterAida Martinez-Sanchez
Jun 15, 2015·Neuroscience·C LeloupL Pénicaud
Jun 18, 2015·Journal of Cellular and Molecular Medicine·Roberto Elizondo-VegaMaria A García-Robles
Nov 12, 2015·The Journal of Biological Chemistry·Jan P RichterAndrew J Sutherland-Smith
Aug 16, 2016·Cell·Cristina García-CáceresMatthias H Tschöp

❮ Previous
Next ❯

Citations

Oct 13, 2020·Diabetologia·Kimberly M AlongeMichael W Schwartz
Jan 7, 2022·Annual Review of Pharmacology and Toxicology·Zaman MirzadehMichael W Schwartz

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.